Trial Profile
Effects of long-term treatment of linagliptin on glycemic control and serum lipids in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Aug 2015 New trial record